美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=APREPITANT"
符合检索条件的记录共 31 条
共 2 页，当前第 1 页
下一页 最后一页 返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
APREPITANT 090999 001 ANDA APREPITANT CAPSULE;ORAL 40MG No No 2012/09/24 2012/09/24 SANDOZ Prescription
APREPITANT 090999 002 ANDA APREPITANT CAPSULE;ORAL 80MG No No 2012/09/24 2012/09/24 SANDOZ Prescription
APREPITANT 090999 003 ANDA APREPITANT CAPSULE;ORAL 125MG No No 2012/09/24 2012/09/24 SANDOZ Prescription
FOSAPREPITANT DIMEGLUMINE 206197 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2016/06/09 2016/06/09 FRESENIUS KABI USA Prescription
FOSAPREPITANT DIMEGLUMINE 204845 001 ANDA FOSAPREPITANT DIMEGLUMINE UNKNOWN UNKNOWN No No 2017/03/28 (TA) -- SAGENT PHARMS None (Tentative Approval)
APREPITANT 207777 001 ANDA APREPITANT CAPSULE;ORAL 40MG No No 2017/10/12 2017/10/12 GLENMARK SPECLT Prescription
APREPITANT 207777 002 ANDA APREPITANT CAPSULE;ORAL 80MG No No 2017/10/12 2017/10/12 GLENMARK SPECLT Prescription
APREPITANT 207777 003 ANDA APREPITANT CAPSULE;ORAL 125MG No No 2017/10/12 2017/10/12 GLENMARK SPECLT Prescription
FOSAPREPITANT DIMEGLUMINE 204015 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 115MG BASE/VIAL No No 2019/09/05 2019/09/05 MYLAN LABS LTD Discontinued
FOSAPREPITANT DIMEGLUMINE 204015 002 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 MYLAN LABS LTD Prescription
FOSAPREPITANT DIMEGLUMINE 205020 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 APOTEX Discontinued
FOSAPREPITANT DIMEGLUMINE 209965 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 MSN Prescription
FOSAPREPITANT DIMEGLUMINE 210064 001 NDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 TEVA PHARMS USA Prescription
FOSAPREPITANT DIMEGLUMINE 210689 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 LUPIN LTD Prescription
FOSAPREPITANT DIMEGLUMINE 211624 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 GENEYORK PHARMS Discontinued
FOSAPREPITANT DIMEGLUMINE 211860 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 BAXTER HLTHCARE CORP Prescription
FOSAPREPITANT DIMEGLUMINE 212309 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 BE PHARMS Prescription
FOSAPREPITANT DIMEGLUMINE 212957 002 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2020/08/20 2020/08/20 NAVINTA LLC Discontinued
FOSAPREPITANT DIMEGLUMINE 204025 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2020/08/26 2020/08/26 ACCORD HLTHCARE Discontinued
FOSAPREPITANT DIMEGLUMINE 213106 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2020/09/08 2020/09/08 QILU PHARM HAINAN Prescription
药品名称，活性成分，申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database